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Human neutrophil defensins, and their analogues incorporating
anionic, hydrophobic or cationic residues at the N- and Ctermini, were
synthesized by solid-phase procedures. The synthetic defensins were
examined for their microbicidal activity against Candida albicans, two
Gram-negative bacteria (Actinobacillus actinomycetemcomitans and
Porphyromonas gingivalis) and two Gram-positive bacteria
(Streptococcus gordonii and Streptococcus mutans). The human
neutrophil peptide 1 (HNP1) and HNP2 were found to be potent
candidacidal agents. HNP3, which differs by one amino acid at the NBiochemical Journal, Vol. 347, No. 3 (May 2000): pg. 633-641. DOI. This article is © Portland Press Limited and permission
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terminus of its sequence, was totally inactive. The Gram-negative
bacteria A. actinomycetemcomitans and P. gingivalis and the
Grampositive bacteria S. gordonii and S. mutans were insensitive to
human defensins. However, the insertion of two basic residues, such
as arginine, at both the N-terminus and the C-terminus of HNP2
significantly enhanced antifungal and antibacterial activity. The
addition of anionic residues, such as aspartic acid, at the N- and Ctermini rendered the molecule totally inactive. The presence of two
hydrophobic amino acids, such as valine, at the N-terminus of HNP2
and of two basic arginine residues at its C-terminus resulted in
molecules that were optimally active against these oral pathogens. The
results suggest that the N- and C-terminal residues in defensin
peptides are the crucial functional elements that determine their
microbicidal potency. The three-dimensional structure of all defensins
constitutes the same amphiphilic -sheet structure, with the polar face
formed by the N- and C-terminal residues playing an important role in
defining microbicidal potency and the antimicrobial spectrum. The
enhance microbicidal activity observed for defensin peptides with two
basic residues at both the N- and C-termini could be due to
optimization of the amphiphilicity of the structure, which could
facilitate specific interactions with the microbial membranes.
Key words: antimicrobial agents, antiparallel -sheet peptides, cysteine-rich
cationic polypeptides, defensin analogues, peptide disulphides.

Introduction
The defensins comprise a group of cysteine-rich cationic
antimicrobial polypeptides that have been identified and characterized
in animals (including humans), plants and insects. They are composed
of 29-42 amino acids and contain three disulphide bonds, formed by
three pairs of cysteine residues [1-4]. Defensins have been isolated
from various tissue sources, such as mammalian trachea, intestine,
tongue and skin, and human plasma, oral mucosa, salivary glands,
saliva and ocular surface [5-13]. Defensins are involved in the oxygenindependent mechanism of the host immune response [14]. The
`classic’ or -defensins were the first group of defensins to be isolated
from human and animal phagocytes, and they comprise a large
subfamily of polypeptides containing 29-36 residues [3,15]. The more
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recently isolated -defensins are more basic and longer (34-42
residues), and are expressed in various mucosa and epithelial cells
[5,16]. The tri-disulphide motifs in - and -defensins differ [16,17].
Defensins have been reported to exhibit powerful antibacterial,
antifungal and antiviral activity against a wide variety of
microorganisms [17-19]. The antibiotic activity of defensins has
generally been attributed to their effects on microbial membranes
[19,20]. They have been reported to interact with lipopolysaccharides
in Gram-negative bacteria, polysaccharides (teichoic acid) in Grampositive bacteria, and phospholipids [17]. The three-dimensional
structures of a few defensin peptides have been reported in the
crystalline state [21] and in solution [22-26]. These studies have
shown that defensins exist as triple-stranded amphiphilic -sheet
structures in aqueous solution, and that the amphiphilicity of the
molecule might facilitate their spontaneous insertion into microbial
membranes, thereby disrupting membrane permeability and integrity
[24,25]. Recent studies have shown that the mechanism of antibiotic
activity of defensins could involve both cell membrane and intracellular
targets [27].
Variations exist in the sequences of -defensins isolated from
different biological sources in humans and animals, particularly at the
N-and C-termini and in the middle portion, as shown in Figure 1. The
sequence identity, the structure reported for a few -defensins and the
conserved disulphide constraints suggest that the overall threedimensional structure of -defensins is maintained, despite variations
in individual sequences. However, the differences in -defensin
sequences have been found to be reflected in their specificity for
microbes and their spectrum of antimicrobial activity. For instance,
human neutrophil defensins HNP1 (human neutrophil peptide 1) and
HNP2 have been reported to be potent candidacidal agents. However,
HNP3, which differs only in one amino acid at the N-terminus, has
been found to be least active against C. albicans [28]. HNP1 and HNP2
have been found to be equipotent in their ability to kill
Capnocytophaga species, and their activity has been reported to be
significantly greater than that of HNP3 [29]. Even though human
defensins (HNP1, HNP2 and HNP3) are not active against Actinobacillus
actinomycetemcomitans, rabbit defensing NP1, which shows variations
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at the N- and C-termini and in the middle portion of the sequence, has
been reported to exert pronounced activity against A.
actinomycetemcomitans strains [29]. Such wide functional diversity
has also been observed for rat defensins of similar structure [30]. The
three-dimensional structure of defensins has been reported to
primarily assume a `basket-like’ amphiphilic structure. The open end
of the basket constituted by the N- and C-terminal residues forms the
polar face, whereas the lower and bottom portion of the basket
assumes the apolar face of the amphiphilic structure [21,25]. The wide
functional diversity observed in parallel with variations in the sequence
at the N- and C-termini seems to indicate that the residues at the
polar face could be the crucial determinants of microbicidal potency
and the antimicrobial spectrum. In this paper we describe a new
method for the large-scale synthesis of -defensins, and investigate
the influence of their N- and C-terminal residues on their antimicrobial
spectrum and microbicidal potency.

Experimental
General materials and methods
Chemicals and solvents were of the highest purity available and
were used without further purification. Amino acid derivatives and pbenzyloxybenzyl alcohol (Wang) resins were purchased from Sigma
Chemical Co. (St. Louis, MO, U.S.A.) and Bachem (Torrance, CA,
U.S.A.). The peptide sequence was assembled using a manual peptide
synthesizer. HPLC was carried out on a Rainin-HPXL system interfaced
to a Macintosh SE/30 computer using a Rainin Dynamax C18 column
(10 mm х 250 mm) coupled to a guard column (10 mm х 50 mm) and
employing acetonitrile/water [each containing 0.1% trifluoroacetic acid
(TFA)] linear gradient elution with a flow rate of 2.0 ml·min−1. The
dried peptide was hydrolysed in sealed tubes for 24 h at 110°C using 6
M HCl in the presence of 1% phenol vapour, and amino acid analysis
was performed on a Perkin—Elmer 420A derivatizer and analyser
system. The amino acid sequence of the peptide (~1 nmol) was
checked by sequence analysis using a Perkin—Elmer Model 477A
protein sequencer. Fast-atom bombardment (FAB) mass analysis was
carried out on an M-Scan VG Analytical ZAB 2-SE high-field mass
spectrometer. A caesium ion gun was used to generate ions for the
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acquired spectra, which were recorded using a PDP 11-250J data
system.

Peptide synthesis and purification
The linear defensin sequences (HNP1, HNP2, HNP3, HNPa, HNPb,
HNPc, HNPd and HNPe) shown in Figure 1 were assembled by standard
solid-phase procedures [31] using Wang resins linked to the Cterminal Fmoc (9-fluorenylmethyloxycarbonyl) amino acid (0.2-0.3
mmol/g). The general scheme employed for the synthesis of defensin
peptides is shown in Scheme 1. The side-chain protecting groups were
the following: Glu, Thr and Tyr, O-tButyl; Trp, tBoc (tbutyloxycarbonyl); Arg, N-2,2,5,7,8-pentamethylchroman-6sulphonyl; N- and C-terminal Cys, Trityl ; Cys-4 and Cys-19, S-tButyl;
Cys-9 and Cys-29, acetamidomethyl (Acm). The coupling reactions
were carried out with a 3-fold excess of Fmoc amino acid in a mixture
(50%, v/v) of N,N-dimethylformamide and dichloromethane using
dicyclohexylcarbodi-imide as the coupling reagent in the presence of
1-hydroxybenzotriazole. Completion of the coupling reaction was
monitored by Kaiser's test [32]. The Fmoc group on the N-terminus
was deprotected in 10 min with a 25% solution of piperidine in
dimethylformamide. The protected peptidyl resin was then treated with
90% (v/v) TFA in dichloromethane containing thioanisole (2.5%) and
dimethyl sulphide (2.5%). When the peptide was cleaved from the
resin, the crude linear peptide (93-95%) was obtained. The N- and Cterminal Cys residues with the S-Trityl protecting group were
deprotected at the same time when the peptide was cleaved from the
resin by treatment with TFA, whereas the Acm and S-tButyl protecting
groups on Cys-4/Cys-19 and Cys-9/Cys-29 respectively were intact.
The crude linear peptides were purified by reverse-phase HPLC on a
Rainin Dynamax-60A C18 column (10 mm х 250 mm) coupled to a
guard column (10mm х 50 mm) employing acetonitrile/water (each
containing 0.1% TFA) linear gradient elution (10-50% acetonitrile in
water over a period of 45-50 min) with a flow rate of 2.0 ml·min−1
(detection at 230 nm and 280 nm). The fractions of each resolved
peak were pooled, lyophilized and subjected to amino acid and
sequence analyses, which identified and verified the authentic peptide
sequence.
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Disulphide-bond formation between the N- and Cterminal cysteine residues
The HPLC-purified linear peptide (0.45 g) with free thiol groups
on the N- and C-terminal cysteine residues was suspended in 2.5 litres
of water to bring the concentration of the peptide to ~0.05 mM, and
the pH was brought to 6.8 by the addition of 0.1M ammonium acetate
solution. A 0.2 M solution of potassium ferricyanide was added in
minute drops over a period of 12 h while maintaining the pH at 6.87.0, until the yellow colour persisted. A 5 ml excess of potassium
ferricyanide was then added to ensure oxidation. The pH of the
solution was maintained at 6.8-7.0 by using 0.1 M ammonium acetate
and 20% acetic acid. The solution was concentrated to 50 ml at 4045°C and then passed through an activated thiol-Sepharose 4B resin
(Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.) column (10
mm х 75 mm) to remove any peptide containing free thiol groups. The
peptide from the column was eluted with 0.1 M ammonium acetate
buffer (pH 6.8). The aqueous peptide solution was pooled and
lyophilized. The dried material was purified by reverse-phase HPLC
using the semi-preparative Rainin Dynamax-60A C18 column, as
described above. The fractions of the major well resolved peak were
pooled, lyophilized and subjected to amino acid and sequence
analyses. The amino acid composition, sequence and mass-spectral
analysis of the purified material verified the correct sequence. The
yield of the purified product was found to be 66-68%.

Disulphide-bond formation between Cys-4 and Cys-19
The purified material obtained as described above was dissolved
in trifluoroethanol (300 ml) and reduced with 12.3 ml of
tributylphosphine at room temperature for 3 h to deprotect the StButyl groups on Cys residues at positions 4 and 19 (Scheme 1). The
reaction mixture was then concentrated to a small volume (2 ml) and
the product was precipitated by the addition of diethyl ether. The
separated solid was filtered and washed with ether (3 х 25 ml) and
dried. The dried material (~0.35 g) was suspended in 2.0 litres of
water to bring the peptide concentration to 0.05 mM and then
subjected to oxidation using a 0.2 M solution of potassium ferricyanide
at pH 6.8, and the peptide was isolated as described in the previous
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section. The dried material was subjected to reverse-phase HPLC and
the fractions of the major resolved peak were pooled and analysed.
The amino acid composition, sequence and mass-spectral analyses
identified the peptide. The yield of the purified product was found to be
56-58%.

Disulphide-bond formation between Cys-9 and Cys-29
The total material obtained after the formation of the second
disulphide bond (~0.3 g) was dissolved in a mixture of water/methanol
(6 :1, v/v) so that the peptide concentration was 0.05 mM. The
peptide solution was stirred while adding a 1 mM solution of iodine
(125 ml) in methanol dropwise during 1 h. The red solution was cooled
to 0 °C and treated with 1 M sodium thiosulphate until the red colour
disappeared. The methanol was removed by rotary evaporation at the
water aspirator and then the material was lyophilized. The crude
material obtained was dissolved in 50 ml of water and passed through
an activated thiol-Sepharose B column (5 mm х 75 mm); the column
was then washed with (3 х 25 ml) 0.1 M ammonium acetate buffer at
pH 6.8. The aqueous solution was lyophilized. The dried material was
purified by reverse-phase HPLC as described above. All fractions of the
well-resolved peaks were pooled and lyophilized. The sequence, massspectral and amino acid analyses of the major component identified it
as the synthetic defensin sequence. The identity of the synthetic
peptide was assessed by comparing its HPLC retention time, CD
spectrum and mass spectrum with those of the native defensin
peptides isolated from human neutrophils. The yield of the product
after HPLC purification was found to be 45-48%.

Organisms and growth conditions
Candida albicans strain ATCC 28366 obtained from the American
Type Culture Collection (Rockville, MD, U.S.A.) and a clinical isolate
from a patient with denture-induced stomatitis (DIS) were used. The
identity of the clinical isolate was verified by the Yeast System (Flow
Laboratories, McLean, VA, U.S.A.). Organisms were streaked on to
Sabouraud Dextrose Agar plates (Difco Laboratories, Detroit, MI,
U.S.A.) and maintained at 4°C. One colony of C. albicans from this
plate was inoculated into 10 ml of yeast synthetic growth medium
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containing sucrose, salts and biotin [33], and incubated for 48 h at
25°C in a shaker rotating at 200 rev./min. After this period, the
population of yeast cells was in late-exponential-phase growth. Cell
morphology was determined by phase-contrast microscopy and found
to be uniformly blastospores. Subcultures were done every 3 days by
inoculating 100 l of 3-day-old culture into 10 ml of fresh synthetic
medium.

Measurement of candidacidal activity
The antifungal activity of the synthetic human neutrophil
defensins and their analogues was assessed in vitro against Candida
albicans. The loss of cell viability is expressed as a function of peptide
concentration. The assay was performed as described for the
candidacidal activity of salivary histatin 5 and its fragments [34]. We
refer to the rapid candidacidal action of peptides as a loss of viability
of cells, since inability of the yeast to replicate following removal of
peptides is considered to represent a non-viable cell. Thus the assay
used in the present study measured only fungicidal activity. Cells from
48 h cultures were harvested, washed and resuspended to a
concentration of 5 х 107 cells/ml in 0.01 M sodium phosphate buffer
(pH 7.4). Stock solutions of peptides (range 0.05-200 M) were made
in 0.01 M sodium phosphate buffer. Peptide concentrations were
determined by amino acid analysis. A microassay system was utilized
in which 100 l of the stock solution of test peptide was incubated with
100 l (5 х 106 cells) of yeast suspension in sterile glass test tubes at
37°C for 1.5 h. Control suspensions consisting of 100 l of cells and
100 l of sodium phosphate buffer were incubated simultaneously.
Each tube of cell suspension was shaken for 10 s every 15 min during
this time. A 100 l aliquot of cells was removed from the tube, diluted
to 5 х 102 cells/ml in sodium phosphate buffer and then vortex-mixed.
Aliquots of 0.5 ml of each suspension were spread on to plates (15
mm х 100 mm) of Sabouraud Dextrose Agar in duplicate. C. albicans
was grown overnight at 37°C, and the candidacidal activity of the test
peptide was assessed as the ratio of colonies per test plate to the
number of colonies on control (no peptide) plates, and expressed as a
percentage.
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Bacterial strains and cultivation
The cultivation of bacterial strains was carried out as described
in our previous publications [35,36]. Briefly, Porphyromonas gingivalis
strains W50 and 381 were maintained on blood agar plates containing
tryptic soy agar (Difco Laboratories) supplemented with hemin (1%),
menadione (0.02%) and de-fibrinated sheep blood (5%).
Actinobacillus actinomycetemcomitans strains Y4 and 67 were
maintained in tryptic soy agar plates containing yeast extract (0.5%).
Streptococcus mutans GS5 and Streptococcus gordonii DL1 were
grown on Todd-Hewitt agar plates. For liquid culture, these bacteria
were grown in their respective broth. All experiments were carried out
in an anaerobic chamber (85% N2, 10% H2 and 5% CO2) (Coy
Laboratory Products), and bacteria were confirmed routinely by
standard microbiological methods.

Bactericidal assay
The bactericidal assays were performed as described previously
[35,36]. The antimicrobial activity of defensins was tested against P.
gingi.alis (W50 and 381), A. actinomycetemcomitans (Y4 and 67), S.
gordonii (GS5) and S. mutans (DL1). Bacterial strains were grown in
freshly prepared broth to 109 cells and subsequently diluted to 106
cells/ml in 10 mM sodium phosphate buffer (pH 7.4). Cells were
harvested and washed twice in sodium phosphate buffer. Washed cells
were incubated with various concentrations of the peptide in a total
volume of 200 l at 37°C in an anaerobic chamber for 1.5 h as
described previously [36]. The cells were diluted to 103 cells/ml and
plated on the respective agar plates. The plates were incubated
anaerobically at 37°C for 6 days, and the number of viable P.
gingivalis colonies was calculated in comparison with the control. In
the case of A. actinomycetemcomitans, S. gordonii and S. mutans, the
colonies were counted after 3 days and compared with the control
plates. The bactericidal activity of the peptide was expressed as [1—
(cell survival after peptide incubation)/(cell survival in buffer alone)] х
100, which represents the percentage killing of the bacterial cells. The
loss of cell viability is expressed as a function of peptide concentration.
The peptide concentration that induced 90% of the maximal loss of cell
viability (EI90) was determined from the concentration-effect curves.
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Purification of native human neutrophil defensins
In order to determine the identity of the synthetic molecules
and to verify the formation of correct disulphide bonds between the
respective cysteine residues, we purified a few native human
defensins. Human neutrophils were isolated from whole blood collected
from healthy human volunteers, as described in our previous
publication [37]. Cell purity (90-95% neutrophils) was assessed by
Wright-Giemsa staining. Leucocytes were homogenized, centrifuged
and chromatographed using the method reported previously [38]. The
mixture of HNP1, HNP2 and HNP3 obtained after initial
chromatographic separation was subjected to reverse-phase HPLC on a
Rainin Dynamax-60A semi-preparative C18 column (10 mm х 250
mm) coupled to a guard column (10 mm х 50 mm) employing
acetonitrile/water (each containing 0.1% TFA) linear gradient elution
(flow rate 2.0 ml·min−1). Processing of 2.8 х 109 cells yielded ~4.5,
4.0 and 4.2 mg of HNP1, HNP2 and HNP3 respectively. The
homogeneity of peptides was examined by reverse-phase HPLC on a
Rainin Dynamax-60A analytical C18 column (4.6 mm х 250 mm)
coupled to a guard column (4.6 mm х 15 mm) employing
acetonitrile/water (each containing 0.1% TFA) linear gradient elution
(flow rate 0.8 ml·min-1) with detection at 230 nm and 280 nm. The
native molecules were further verified by SDS/PAGE, cationic PAGE,
amino acid analysis and FAB-MS analysis.

CD spectroscopy
CD measurements were carried out on an Aviv 62DS spectropolarimeter equipped with a thermostatic temperature controller and
interfaced to an IBM microcomputer. CD spectra were recorded in a
quartz cell of 0.05 mm pathlength at 30°C between 180 and 250 nm,
using a 1.0 nm bandwidth and a scanning rate of 10 nm/min with a
wavelength step of 0.2 nm and a time constant of 2 s. The region from
250 to 400 nm was recorded using a 1 mm pathlength cell. Peptides
were dissolved in 10 mM sodium phosphate buffer at pH 7.2 to a
concentration of 0.1-0.3 mM. CD band intensities were determined as
molar ellipticity ([θ]M), in deg·cm2·dmol−1.
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RESULTS AND DISCUSSION
Synthesis of defensin peptides
The method described for the synthesis of defensin peptides
yielded nearly 17-20% of final purified product. The identity of the
synthetic molecules was verified by comparing the SDS/PAGE and
cationic PAGE profiles and the CD and FABMS spectra with those of the
native peptides. The FAB mass spectra of synthetic and native HNP1
showed the molecular ion cluster centered at m/z 3442, which is
consistent with the molecular mass. The intensity of the disulphide nσ* CD bands that generally occur between 250 and 320 nm is highly
sensitive to the dihedral angle, flexibility and chirality of the disulphide
chromophore [39,40]. Hence we examined the CD bands in this region
for both synthetic peptides and native molecules. The CD spectra of
synthetic and native HNP1 in the region 250-400 nm, which reflects
the contribution of disulphide n-σ* and of aromatic residues, were
comparable. The CD spectra of the synthetic and native HNP1 in the
region between 180 and 250 nm, which represents the peptide
secondary structure, were almost identical. Analysis on SDS/12.5%PAGE indicated that the native and synthetic molecules migrated to
the same extent. In addition, the microbicidal activity of synthetic and
native HNP1 (described in subsequent sections) were also comparable.
Collectively, the data suggest that the synthetic molecules are identical
with the native peptides.
The formation of the three distinct disulphide bonds between the
respective cysteine residues is the major task in the synthesis of
defensins. Simultaneous oxidation of the six thiol groups might lead to
the formation of undesired disulphide bridges and polymerized sideproducts, leading to a very poor yield of defensins. We found a high
percentage of polymerized sideproducts when all six thiol groups were
oxidized simultaneously, even at very low peptide concentration. The
formation of undesired polymerized side-products during the
simultaneous oxidation of all six or four cysteine residues has been
reported [41], although it might be possible to purify trace amounts of
the correct peptide from these side-products [42]. Therefore we
rationally selected three different protecting groups, namely Trityl (for
N- and C-terminal cysteines), S-tButyl (for Cys-4 and Cys-19) and
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Acm (for Cys-9 and Cys-29), for the three pairs of cysteine residues
that form the disulphide bonds. The three thiol protecting groups were
deprotected under different conditions in three different stages and
oxidized to form the respective disulphide bridges, as described in
Scheme 1. Reverse-phase HPLC traces of the crude peptide with one
disulphide bond between Cys-1 and Cys-30, of that with two
disulphides between Cys-1 and Cys-30 and between Cys-4 and Cys19, of the crude HNP1 and of the purified HNP1 are provided in Figure
2.
The scheme employed for the synthesis of defensins eliminates
the formation of any undesired disulphide bonds.Wefirst cyclized the
peptide by forming the disulphide bridge between the N- and Cterminal cysteines, thereby allowing the other cysteine residues to
achieve a favourable orientation in space to ease the formation of
disulphide bonds between the respective cysteine residues. The threedimensional structure of defensins clearly suggests that the folding of
the C-terminus towards the N-terminus brings the other two pairs of
cysteine residues into close proximity, favouring the formation of the
disulphide bonds [21,25]. Hence we chose to form the first disulphide
bridge between the N- and C-terminal Cys residues. The trace
amounts of any free thiolcontaining sequences at each stage of
formation of disulphide bonds were removed by treatment with a
column of activated thiol-Sepharose 4B resin (Amersham Pharmacia
Biotech), which selectively adsorbs even trace amounts of thiolcontaining sequences. The use of activated thiol-Sepharose 4B resin at
each stage of formation of disulphide bonds eliminates the
accumulation of any thiol-containing products. The oxidation of
cysteine residues in all three different stages was carried out in
solution at a peptide concentration of 0.05 mM, with vigorous stirring
to minimize polymerization. Chemical synthesis of a few defensing
peptides using only two different protecting groups, and formation of
disulphide bonds in two stages, has been reported previously, with a
final yield of only 7% [41]. The simultaneous removal of the protecting
groups on four cysteine residues and oxidation of the thiol groups
might have led to the formation of undesired side-products, and
accordingly lowered the percentage yield of the products. The method
described in this paper, using three distinct thiol protecting groups and
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forming disulphide bonds in three different stages, is very efficient,
giving a high yield (17-20%) of pure defensin peptides.

Candidacidal activity
The efficacy of defensin peptides in inducing loss of viability of
Candida albicans was measured at various peptide concentrations
(Figure 3). The data provided in Figure 3 are for the DIS strain; C.
albicans strain 28366 has been found to be 10-20% more susceptible
to these peptides. The percentage loss of viability of C. albicans
induced by synthetic HNP1 at various concentrations (Figure 3) is
comparable with that observed for the native molecule, suggesting
identity of the molecules. The EI90 value for HNP1 was ~14 M. The
candidacidal activity of HNP2 was nearly 5-fold lower than that of
HNP1. The EI90 for HNP2, which lacks the N-terminal Ala residue, was
~65 M, indicating the importance of the residues preceding cysteine
at the N-terminus. The Candida albicans strains were insensitive to
HNP3, which has a negatively charged Asp residue at this position. The
results are consistent with the previously reported candidacidal activity
of human defensins [28], although the C. albicans strains and the
assay procedures used were different.
HNPa, which has two Asp residues at both the N- and the Cterminus, was totally inactive against C. albicans, suggesting that
negatively charged side chains at the termini render the molecule
inactive. Compared with HNP1, a 5-fold increase in candidacidal
activity was observed when two polar amino acids, such as threonine,
were present at the N- and C-termini, as in the case of HNPc (EI90 ~ 3
M). HNPb, which has two hydrophobic valine residues at the Nterminus and two cationic arginine residues at the C-terminus, had 2fold greater candidacidal activity (EI90 ~ 6 M). Compared with HNPb,
a 2-fold increase in candidacidal activity was observed for HNPd (EI90
~ 1.5 M), which has two threonine residues in place of valines at the
N-terminus. The presence of two arginine residues at both the N- and
the C-terminus enhanced candidacidal activity significantly : HNPe
(EI90 ~ 0.5 M) was 10-fold more potent than HNPb, and markedly
(30-fold) more active than HNP1. Collectively, the candidacidal
activities of human defensins and their analogues suggest that polar
and charged side chains at the N- and C-termini, respectively
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preceding and succeeding the cysteine residues, appear to be
functionally very important.

Bactericidal activity
The microbicidal activities of human neutrophil defensins and
their analogues against the Gram-negative P. gingivalis and A.
actinomycetemcomitans strains are summarized in Figures 4 and 5
respectively. P. gingivalis (strains W50 and 381) and A.
actinomycetemcomitans (strains Y4 and 67) were insensitive to human
neutrophil defensins HNP1, HNP2 and HNP3 up to a peptide
concentration of 200 M. The strains were also insensitive to the
analogue HNPa, which has two Asp residues at both the N- and Ctermini. Both P. gingivalis and A. actinomyctemcomitans strains were
highly sensitive to the analogues HNPb, HNPc, HNPd and HNPe, which
have two additional residues at the N- and C-termini of human
defensing peptides (Figures 4 and 5). HNPb, which has two
hydrophobic valines preceding the cysteine at the N-terminus and two
arginines following the cysteine at the C-terminus, was microbicidal
against both P. gingivalis and A. actinomycetemcomitans (Figures 4
and 5). The EI90 for this peptide was ~ 25 M. This HNPb peptide is
similar to rabbit defensin peptide NP1, which has two valine and two
arginine residues at the N- and C-termini respectively. However, NP1
has variations in the middle portion of the sequence as compared with
human defensins HNP1, HNP2 and HNP3 (Figure 1). Therefore the
comparable cidal activities of HNPb and NP1 seem to indicate that the
residues at the N- and C-termini of defensin peptides may be
functionally very important for microbicidal activity and specificity. The
microbicidal activity of NP1 against A. actinomycetemcomitans
reported previously is comparable with our present results with HNPb
[29].
The presence of two polar side chains, such as threonine
residues, at the N- and C-termini of human defensins also elicited
similar antimicrobial activity against these two Gram-negative bacteria
(Figures 4 and 5). However, the presence of threonines appeared to
increase the cidal potency slightly. The EI90 for HNPc was ~ 14 M,
suggesting an approx. 2-fold increase in microbicidal activity as
compared with HNPb. The presence of two threonine residues at the NBiochemical Journal, Vol. 347, No. 3 (May 2000): pg. 633-641. DOI. This article is © Portland Press Limited and permission
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terminus and two arginine residues at the C-terminus, as in the case
of HNPd (EI90 ~ 5 M), enhanced the activity 5-fold as compared with
HNPb (Figures 4 and 5). The addition of two polar and charged
arginine residues at the N- and C-termini, as in the case of HNPe (EI90
~ 1 M), enhanced microbicidal activity 25-fold as compared with
HNPb (Figures 4 and 5).
Thus, even though HNP1 and HNP2 are potent antifungal agents
against C. albicans, they are minimally active against the Gramnegative bacteria P. gingivalis and A. actinomycetemcomitans. The
insertion of two valine side chains at the N-terminus and two arginine
residues at the C-terminus of HNP2 elicits antibacterial activity against
these organisms. This suggests that the additional N- and C-terminal
side chains are indeed necessary to elicit optimal antibacterial activity
against these organisms. Comparison of the activities of HNPb, HNPc,
HNPd and HNPe suggests that the antibacterial activity tends to
increase with the increase in polarity caused by the additional residues
at the N- and C-termini. The data suggest that the presence of two
additional polar and charged side chains preceding and following the
cysteine residues at the N- and C-termini respectively of human
defensins is required for optimal antibacterial activity.
Streptococcus gordonii (strain GL1) and Streptococcus mutans
(strain GS5) were also insensitive to the human neutrophil defensins
HNP1, HNP2 and HNP3 and the analogue HNPa. However, both strains
were sensitive to HNPb, HNPc, HNPd and HNPe (Figure 6), at slightly
higher concentrations than were required for activity against the
Gram-negative bacteria P. gingi.alis and A. actinomycetemcomitans.
At a concentration of 55 M, 90% killing was observed for HNPb. HNPc
(EI90 ~ 27 M), which has two polar threonine residues at both the Nand C-termini, was slightly (2-fold) more active than HNPb. HNPd,
which has two threonines and two arginines at the N- and C-termini
respectively, was nearly 5-fold more active (EI90 ~ 15 M) than HNPb
(Figure 6). The presence of two arginines at both the N- and C-termini
caused HNPe to be significantly more active (EI90 ~ 6 M) than HNPb.
The trend for the increase in microbicidal activity with sequence
alterations at their N- and C-termini appears to be the same for Grampositive and Gram-negative organisms (Figure 6). In other words, the
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antibacterial activity of defensin peptides increases with an increase in
the cationic charge and polarity of the residues preceding and
following cysteine residues at the N- and C-termini respectively. The
slight differences in the cidal potencies of the defensin analogues
observed for Gram-negative as compared with Gram-positive
organisms could be due to differences in membrane structure and
composition of lipids. Defensin-like peptides have been reported to
have better antimicrobial activity against Gram-negative bacteria, and
their activity has been related to their ability to permeabilize the outer
membrane [43,44].

Molecular structure and antimicrobial activity
-Defensins isolated from various biological sources in humans
and animals show conservation of the three disulphide bridges and
retain nearly 50% sequence identity. There are variations in the
sequences at the N- and C-termini and in the middle portion of these
peptides. These differences have been found to be reflected in their
antimicrobial spectrum and specificity of organisms for which they are
cidal [14,28]. This functional diversity observed for similarly structured
molecules raises interest in identifying the crucial residues responsible
for their specificity and antimicrobial potency. Hence we selected the
human neutrophil defensins HNP1, HNP2 and HNP3, which have
identical sequences from the N-terminal cysteine to the Cterminal
cysteine, and examined analogues with minor variations only at the Nand C-termini, to assess unambiguously the influence of terminal
residues on their antimicrobial spectrum and antimicrobial potency.
HNP2, which does not have any additional residues preceding
the N-terminal cysteine or following the C-terminal cysteine (Figure 1),
is an optimally active candidacidal agent. The presence of an Ala
residue at the N-terminus enhances the candidacidal activity, as
observed in the case of HNP1 (Figure 3). On the other hand, the
presence of a negatively charged Asp residue at this position (HNP3)
renders the molecule totally inactive against C. albicans. HNP1, HNP2
and HNP3 do not exhibit any microbicidal activity against the Gramnegative bacteria P. gingivalis and A. actinomycetemcomitans or the
Gram-positive bacteria S. gordonii and S. mutans. The same effect is

Biochemical Journal, Vol. 347, No. 3 (May 2000): pg. 633-641. DOI. This article is © Portland Press Limited and permission
has been granted for this version to appear in e-Publications@Marquette. Portland Press Limited does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Portland Press Limited.

16

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

observed for HNPa, which has two Asp residues at both the N- and Ctermini, indicating that negative charge at these positions renders
defensins inactive. However, the presence of two valines at the
N-terminus and two arginines at the C-terminus renders human
defensins active against the Gram-negative and Gram-positive
organisms examined in this investigation. Antibacterial potency is also
enhanced by the presence of polar residues, such as threonine, and
significantly enhanced by the presence of positively charged arginine
residues, as shown by the relative antibacterial and candidacidal
activities of HNPb, HNPc, HNPd and HNPe (Figures 3-6). An arginine
residue has a hydrophobic hydrocarbon chain attached to a polar and
charged guanidine function. The enhanced microbicidal activity
observed for HNPe, and comparison of its activity with that of the
other analogues, seems to suggest that the interactions of defensins
with microbes could involve hydrophobic, hydrogen-bonding and
electrostatic interactions. It is also possible that an increase in the
cationic charge preceding the N-terminal cysteine and following the Cterminal cysteine could be an important determinant of the
antimicrobial spectrum and microbicidal potency of the defensins.
However, residues with polar side chains, such as threonine, in these
positions also elicit high cidal potency against the organisms tested, as
shown by the microbicidal activities of HNPc and HNPd.
The three-dimensional structure of defensins established by Xray diffraction and NMR studies contains an amphiphilic three-stranded
antiparallel -sheet structure [21,24,25]. The molecules assume a
basket-like structure. The open end of the basket constituted by the Nand C-terminal residues forms the polar face, whereas the lower and
bottom portion of the basket assumes the apolar face of the
amphiphilic structure. The presence of two residues both preceding
and following the cysteines at the N- and C-termini respectively might
not alter the overall three-dimensional structure of the molecules. The
enhanced activity of defensin analogues with an additional two
residues at both the N- and C-termini suggests that the projecting side
chains at the polar face of the amphiphilic structure could, indeed, be
crucial requirements for their specificity and microbicidal activity. The
increase in microbicidal activity observed for analogues with polar and
charged residues at the N- and C-termini correlates with an increase in
polarity of the polar face of the amphiphilic structure. Similar effects
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may be observed by altering the hydrophobicity of the apolar face of
the amphiphilic molecule. However, additional data are required to
support this argument. Nevertheless, the present data provide support
for the proposal that the N- and C-terminal residues preceding and
following the cysteine residues respectively are important functional
elements for the antimicrobial spectrum and microbicidal potency of
defensins. This could be due to an alteration in the amphiphilicity of
the molecule that might have a profound influence on microbial
membranes, which differ in their structure and lipid composition
depending on the micro-organisms involved.
In summary, the synthetic scheme described in this paper
represents a convenient procedure for the large-scale synthesis of
defensins, which have potential applications in the pharmaceutical
industry. The present studies suggest that the two residues at the Nand C-termini that respectively precede and follow cysteine residues
could be the determinants of the microbicidal potency and the
antimicrobial spectrum of defensins. Attempts to compromise the
amphiphilicity of the defensin structure by altering the polarity of the
polar face appear to significantly modify specificity and microbicidal
potency. Hence, by rationally choosing these residues, it should be
posssible to obtain potent antimicrobial agents to target selected
infectious pathogens.
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Figure 1 Amino acid sequences of human (HNP) and rabbit (NP) defensins and
synthetic analogues
The one-letter symbols are used for amino acids in the sequences [45].
Conserved amino acid residues are in bold and underlined. The broken lines
indicate the disulphide bridges between the respective cysteine residues.
HNP1, HNP2 and HNP3 are native peptides; HNPa, HNPb, HNPc, HNPd and
HNPe are synthetic analogues.
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Scheme 1 Scheme and protecting groups employed for the synthesis of
human neutrophil defensins and their analogues
The sequence shown in the scheme is that of HNP1. tBu, tertiarybutyl ; Trt,
Trityl ; Xa, O-tButyl ; Xb, N-2,2,5,7,8-pentamethylchroman-6-sulphonyl ; Xc,
N-Trityl ; Xd, tBoc.
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Figure 2 Reverse-phase HPLC of crude peptide intermediates and purified
human defensin HNP1
The solvent system employed was acetonitrile/water (both containing 0.1%
TFA). (a) Crude peptide with one disulphide bond between Cys-1 and Cys-30;
(b) crude peptide with two disulphide bonds, between Cys-1 and Cys-30 and
between Cys-4 and Cys-19 ; (c) crude HNP1; (d) purified HNP1. The gradient
used is indicated by the broken line (% acetonitrile). Peptide samples (C150
lg) were loaded into an injection loop of 250 l capacity and detected at 230
nm.
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Figure 3 Concentration-dependence of loss of viability of Candida albicans
(DIS) induced by human neutrophil defensins and their analogues
Left panel: a, native HNP1; b, synthetic HNP1; c, synthetic HNP2; d, synthetic
HNP3. Right panel: a, HNPb; b, HNPc; c, HNPd; d, HNPe; e, HNPa. C. albicans
cells (DIS) were incubated for 1.5 h at 37°C with defensin peptides (0.05-200
M) as described in the Experimental section. Loss of cell viability is
expressed as [1— (cell survival after peptide incubation)/(cell survival in
buffer alone)] х 100. Each data point is the mean (±S.D.) of duplicate
determinations from three independent experiments

Biochemical Journal, Vol. 347, No. 3 (May 2000): pg. 633-641. DOI. This article is © Portland Press Limited and permission
has been granted for this version to appear in e-Publications@Marquette. Portland Press Limited does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Portland Press Limited.

24

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 4 Concentration-dependence of loss of viability of Porphyromonas
gingivalis strains W50 (left) and 380 (right) induced by human neutrophil
defensing analogues HNPb (a), HNPc (b), HNPd (c) and HNPe (d)
P. gingivalis cells were incubated for 1.5 h at 37°C with defensin peptides
(0.05-200 M) as described in the Experimental section. Loss of cell viability
is expressed as [1 — (cell survival after peptide incubation)/(cell survival in
buffer alone)] х 100. Each data point is the mean (±S.D.) of duplicate
determinations from three independent experiments.
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Figure 5 Concentration-dependence of loss of viability of Actinobacillus
actinomycetemcomitans strains Y4 (left) and 67 (right) induced by human
neutrophil defensin analogues HNPb (a), HNPc (b), HNPd (c) and HNPe (d)
A. actinomycetemcomitans cells were incubated for 1.5 h at 37°C with
defensin peptides (0.05-200 M) as described in the Experimental section.
Loss of cell viability is expressed as [1 — (cell survival after peptide
incubation)/(cell survival in buffer alone)] х 100. Each data point is the mean
(±S.D.) of duplicate determinations from three independent experiments.
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Figure 6 Concentration-dependence of loss of viability of Streptococcus
gordonii DL1 (left) and Streptococcus mutans GS5 (right) induced by human
neutrophil defensin analogues HNPb (a), HNPc (b), HNPd (c) and HNPe (d)
S. gordonii and S. mutans cells were incubated for 1.5 h at 37°C with
defensin peptides (0.05-200 M) as described in the Experimental section.
Loss of cell viability is expressed as [1 — (cell survival after peptide
incubation)/(cell survival in buffer alone)] х 100. Each data point is the mean
(±S.D.) of duplicate determinations from three independent experiments
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